Cash-strapped TME Pharma loses partner, prompting eye drug strategy rethink

… -year extension. Apr 2, 2024 09:10am. Théa pens $280M deal for Iolyx's phase 3-ready dry eye disease drug. Dec 3, 2025 08:25am. See more articles.

Source: google.com